KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Accumulated Expenses (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Accumulated Expenses for 16 consecutive years, with $12.0 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 1.23% to $12.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.0 million through Dec 2025, down 1.23% year-over-year, with the annual reading at $12.0 million for FY2025, 1.23% down from the prior year.
  • Accumulated Expenses for Q4 2025 was $12.0 million at Biolife Solutions, up from $10.9 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $12.1 million in Q4 2024, with the low at $183000.0 in Q2 2024.
  • Average Accumulated Expenses over 5 years is $7.1 million, with a median of $8.0 million recorded in 2024.
  • The sharpest move saw Accumulated Expenses crashed 98.19% in 2024, then surged 5762.9% in 2025.
  • Over 5 years, Accumulated Expenses stood at $1.7 million in 2021, then skyrocketed by 490.7% to $9.8 million in 2022, then dropped by 6.76% to $9.1 million in 2023, then soared by 32.91% to $12.1 million in 2024, then decreased by 1.23% to $12.0 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $12.0 million, $10.9 million, and $9.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.